Blood Test News and Research

RSS

Blood test detects early stage ovarian cancer with 99 percent accuracy

Researchers at Yale School of Medicine have developed a blood test with enough sensitivity and specificity to detect early stage ovarian cancer with 99 percent accuracy.

13 Feb 2008

Health care providers play key role in likelihood their patients are screened for colorectal cancer

The findings suggest that interventions targeting both the provider and the patient are needed to boost colorectal cancer screening rates, and in particular must take into account patient barriers such as concerns about payment and worries that cancer will be discovered.

12 Feb 2008

Revelation of new genes linked to prostate cancer could single out high risk men

The discovery by researchers of at least ten new genes associated with prostate cancer could in future be used to accurately identify high-risk men.

11 Feb 2008

Seniors more likely to deny smoking when asked

More elderly adults are lighting up cigarettes and not reporting their nicotine habits to doctors and others, according to findings from one of the first studies to examine the accuracy of self-reported smoking habits by age, race and gender of adults 18 years and older by researchers at the Case Western Reserve University School of Dental Medicine and other university collaborators.

8 Feb 2008

Australian gene test opens door to personalised care

Australian researchers have led a study published in the New England Journal of Medicine that shows a simple blood test can allow doctors to predict which HIV patients will have a side effect, known as a hypersensitivity reaction, to a particular medication before it is prescribed.

6 Feb 2008

Experimental biomarker test beats PSA in detecting prostate cancer

An experimental biomarker test developed by researchers at the University of Michigan more accurately detects prostate cancer than any other screening method currently in use, according to a study published in the February 1 issue of Cancer Research, a journal of the American Association for Cancer Research.

5 Feb 2008

Stanford study finds transplant patient thrives 2 years after stopping immunosuppressive drugs

Luck smiled on Larry Kowalski when his brother agreed to donate a kidney Kowalski needed to live.

24 Jan 2008

Boston IVF to offer test of women's biological clock in the northeast

Boston IVF has announced it will be the first IVF center in the northeast to offer Repromedix's Plan Ahead test, an innovative blood test that provides an assessment of a woman's egg supply by combining multiple factors including the measurement of ovary-related hormones AMH, Inhibin B, and FSH.

22 Jan 2008

Previously unknown Merkel cell polyomavirus linked to deadly skin cancer

A new strategy to hunt for human viruses described in this week's issue of the journal Science by the husband-and-wife team who found the cause of Kaposi's sarcoma has revealed a previously unknown virus strongly associated with another rare but deadly skin cancer called Merkel cell carcinoma.

18 Jan 2008

Discovery opens door to 'personalized' asthma therapy

In the last few years, "personalized medicine" using genetic or other molecular biology-based diagnostic tests to customize treatment for a particular patient has emerged as a powerful new tool for health care.

18 Jan 2008

Takeda submits NDA for Alogliptin (SYR-322) in the U.S.

Takeda Pharmaceutical Company Limited (Takeda) has announced that Takeda Global Research & Development Center, Inc. submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for alogliptin (development code: SYR-322), a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes.

7 Jan 2008

FDA clears first rapid blood test for MRSA

The U.S. Food and Drug Administration (FDA) has announced it has cleared for marketing the first rapid blood test for the drug-resistant staph bacterium known as MRSA (methicillin-resistant Staphylococcus aureus), which can cause potentially deadly infections.

3 Jan 2008

Microchip blood test detects cancers earlier

A new blood test which uses microchip technology may offer doctors the opportunity to detect cancers earlier and also monitor cancer treatment.

20 Dec 2007

Reasons for low colorectal cancer screening rates

Two recently released studies confirm an alarming reality, that a majority of Americans who should be getting screened for colorectal cancer are not.

18 Dec 2007

DAB2IP gene linked to aggressive prostate cancer

Results from two genome-wide association studies have identified a genetic variant of the DAB2IP gene that is associated with the risk of aggressive prostate cancer.

13 Dec 2007

Carbamazepine based drugs to include new advice for patients with Asian ancestry

The U.S. Food and Drug Administration today announced that the manufacturers of drugs containing the active ingredient carbamazepine have agreed to add to the drugs' labeling a recommendation that, before starting therapy with the drugs, patients with Asian ancestry get a genetic blood test that can identify a significantly increased risk of developing a rare, but serious, skin reaction.

13 Dec 2007

Potential blood test to detect lung cancer

A test for four blood proteins may provide a less-invasive follow-up for patients who have suspicious lesions on chest radiographs or computerized tomography (CT) scans, according to a new study led by Duke University Medical Center researchers.

10 Dec 2007

New upper limit defined for normal ALT in adolescent males

A new cohort study of adolescent offenders in Australia has identified an upper limit for alanine aminotransferase (ALT) that is more sensitive for the diagnosis of liver disease.

4 Dec 2007

Potential early warning system for lung cancer identified

The study, published in the journal Thorax, found that changes in the blood can be detected which signal the presence of lung cancer, and that these changes can be present years before outward symptoms become apparent.

29 Nov 2007

Whole-body positron emission tomography can reassure cervical cancer patients

Whole-body PET (positron emission tomography) scans done three months after completion of cervical cancer therapy can ensure that patients are disease-free or warn that further interventions are needed, according to a study at Washington University School of Medicine in St. Louis.

21 Nov 2007